Epigenetics and micrornas in cancer

Petra M. Wise, Kishore B. Challagundla, Muller Fabbri

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

MicroRNAs (miRNAs) are small noncoding RNA which regulate gene expression. In addition to their “classical†mechanism of action (targeting of messenger RNAs by binding to partially complementary sequences in their 3′-untranslated region), it has been shown that miRNAs can also regulate gene expression by affecting the epigenetics status of genes. These miRNAs, called epi-miRNAs, act by directly silencing key effectors of the epigenetic machinery, such as DNA methyltransferases (DNMTs), histone deacetylases (HDACs), and Polycomb Repressive Complex (PRC) genes. Moreover, miRNAs, like any other proteic coding gene, are also regulated by epigenetic mechanisms. Overall, this two-way interaction between the miRNome and the epigenome is critically involved in the dysregulation of miRNAs observed in human cancer, and at least in part responsible for human carcinogenesis. A better understanding of the dynamic between miRNAs and epigenetics in cancer is leading to the identification of new molecular anticancer targets.

Original languageEnglish (US)
Title of host publicationCancer Immunology
Subtitle of host publicationA Translational Medicine Context
PublisherSpringer Berlin Heidelberg
Pages285-294
Number of pages10
ISBN (Electronic)9783662440063
ISBN (Print)9783662440056
DOIs
StatePublished - Jan 1 2015

Fingerprint

MicroRNAs
Epigenomics
Neoplasms
Genes
Gene Expression
Small Untranslated RNA
Histone Deacetylases
Methyltransferases
3' Untranslated Regions
Carcinogenesis
Messenger RNA
DNA

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Wise, P. M., Challagundla, K. B., & Fabbri, M. (2015). Epigenetics and micrornas in cancer. In Cancer Immunology: A Translational Medicine Context (pp. 285-294). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-44006-3_16

Epigenetics and micrornas in cancer. / Wise, Petra M.; Challagundla, Kishore B.; Fabbri, Muller.

Cancer Immunology: A Translational Medicine Context. Springer Berlin Heidelberg, 2015. p. 285-294.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wise, PM, Challagundla, KB & Fabbri, M 2015, Epigenetics and micrornas in cancer. in Cancer Immunology: A Translational Medicine Context. Springer Berlin Heidelberg, pp. 285-294. https://doi.org/10.1007/978-3-662-44006-3_16
Wise PM, Challagundla KB, Fabbri M. Epigenetics and micrornas in cancer. In Cancer Immunology: A Translational Medicine Context. Springer Berlin Heidelberg. 2015. p. 285-294 https://doi.org/10.1007/978-3-662-44006-3_16
Wise, Petra M. ; Challagundla, Kishore B. ; Fabbri, Muller. / Epigenetics and micrornas in cancer. Cancer Immunology: A Translational Medicine Context. Springer Berlin Heidelberg, 2015. pp. 285-294
@inbook{154a27d15a344b7d97d6573a9053ce0e,
title = "Epigenetics and micrornas in cancer",
abstract = "MicroRNAs (miRNAs) are small noncoding RNA which regulate gene expression. In addition to their {\^a}€œclassical{\^a}€ mechanism of action (targeting of messenger RNAs by binding to partially complementary sequences in their 3{\^a}€²-untranslated region), it has been shown that miRNAs can also regulate gene expression by affecting the epigenetics status of genes. These miRNAs, called epi-miRNAs, act by directly silencing key effectors of the epigenetic machinery, such as DNA methyltransferases (DNMTs), histone deacetylases (HDACs), and Polycomb Repressive Complex (PRC) genes. Moreover, miRNAs, like any other proteic coding gene, are also regulated by epigenetic mechanisms. Overall, this two-way interaction between the miRNome and the epigenome is critically involved in the dysregulation of miRNAs observed in human cancer, and at least in part responsible for human carcinogenesis. A better understanding of the dynamic between miRNAs and epigenetics in cancer is leading to the identification of new molecular anticancer targets.",
author = "Wise, {Petra M.} and Challagundla, {Kishore B.} and Muller Fabbri",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-662-44006-3_16",
language = "English (US)",
isbn = "9783662440056",
pages = "285--294",
booktitle = "Cancer Immunology",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Epigenetics and micrornas in cancer

AU - Wise, Petra M.

AU - Challagundla, Kishore B.

AU - Fabbri, Muller

PY - 2015/1/1

Y1 - 2015/1/1

N2 - MicroRNAs (miRNAs) are small noncoding RNA which regulate gene expression. In addition to their “classical†mechanism of action (targeting of messenger RNAs by binding to partially complementary sequences in their 3′-untranslated region), it has been shown that miRNAs can also regulate gene expression by affecting the epigenetics status of genes. These miRNAs, called epi-miRNAs, act by directly silencing key effectors of the epigenetic machinery, such as DNA methyltransferases (DNMTs), histone deacetylases (HDACs), and Polycomb Repressive Complex (PRC) genes. Moreover, miRNAs, like any other proteic coding gene, are also regulated by epigenetic mechanisms. Overall, this two-way interaction between the miRNome and the epigenome is critically involved in the dysregulation of miRNAs observed in human cancer, and at least in part responsible for human carcinogenesis. A better understanding of the dynamic between miRNAs and epigenetics in cancer is leading to the identification of new molecular anticancer targets.

AB - MicroRNAs (miRNAs) are small noncoding RNA which regulate gene expression. In addition to their “classical†mechanism of action (targeting of messenger RNAs by binding to partially complementary sequences in their 3′-untranslated region), it has been shown that miRNAs can also regulate gene expression by affecting the epigenetics status of genes. These miRNAs, called epi-miRNAs, act by directly silencing key effectors of the epigenetic machinery, such as DNA methyltransferases (DNMTs), histone deacetylases (HDACs), and Polycomb Repressive Complex (PRC) genes. Moreover, miRNAs, like any other proteic coding gene, are also regulated by epigenetic mechanisms. Overall, this two-way interaction between the miRNome and the epigenome is critically involved in the dysregulation of miRNAs observed in human cancer, and at least in part responsible for human carcinogenesis. A better understanding of the dynamic between miRNAs and epigenetics in cancer is leading to the identification of new molecular anticancer targets.

UR - http://www.scopus.com/inward/record.url?scp=84942836534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942836534&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-44006-3_16

DO - 10.1007/978-3-662-44006-3_16

M3 - Chapter

AN - SCOPUS:84942836534

SN - 9783662440056

SP - 285

EP - 294

BT - Cancer Immunology

PB - Springer Berlin Heidelberg

ER -